Clinical trials for HIV prevention and treatment in Washington, D.C.
The District of Columbia Clinical Trials Unit (DC CTU)
This study is looking for people in Washington, D.C. who are living with or at risk for HIV to join clinical trials that aim to improve treatment and prevention methods, all while making sure participants feel safe and supported throughout the process.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10986089 on NIH RePORTER |
What this research studies
The District of Columbia Clinical Trials Unit (DC CTU) focuses on conducting clinical trials for individuals living with or at risk for HIV in Washington, D.C. This initiative combines two established clinical research sites to enhance the management and execution of therapeutic and prevention studies. The research emphasizes community engagement and aims to recruit a diverse participant pool, ensuring high retention rates and participant safety. By leveraging local resources and partnerships, the DC CTU seeks to improve the quality of clinical trials and outcomes for participants.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals aged 21 and older who are living with HIV or are at risk of contracting the virus, particularly within the African American community.
Not a fit: Patients who are not at risk for HIV or do not have HIV may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment and prevention strategies for HIV, benefiting individuals at risk or living with the virus.
How similar studies have performed: Previous research has shown success in similar community-focused clinical trial approaches, indicating potential for impactful outcomes.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Magnus, Manya — George Washington University
- Study coordinator: Magnus, Manya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.